Puma Biotechnology, Inc. financial data

Symbol
PBYI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10880 Wilshire Blvd., Suite 2150, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
INNOVATIVE ACQUISITIONS CORP (to 10/4/2011)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % -25.5%
Quick Ratio 6.28 % -26.7%
Debt-to-equity 289 % -52.3%
Return On Equity 41.5 %
Return On Assets 10.7 %
Operating Margin 13.3 % +9.38%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.1M shares +3.19%
Common Stock, Shares, Outstanding 49.1M shares +3.21%
Entity Public Float 141M USD +26.4%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares +3.13%
Weighted Average Number of Shares Outstanding, Diluted 49.2M shares +2.83%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 244M USD +6.3%
Research and Development Expense 60.2M USD -30.3%
Costs and Expenses 211M USD +4.92%
Operating Income (Loss) 32.4M USD +16.3%
Nonoperating Income (Expense) -7.73M USD +66.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 24.7M USD +441%
Income Tax Expense (Benefit) 1.43M USD +69.4%
Net Income (Loss) Attributable to Parent 23.2M USD +251%
Earnings Per Share, Basic 0.48 USD/shares +500%
Earnings Per Share, Diluted 0.47 USD/shares +488%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.3M USD -17.8%
Marketable Securities, Current 29.5M USD +812%
Cash, Cash Equivalents, and Short-term Investments 89.9M USD +86.3%
Accounts Receivable, after Allowance for Credit Loss, Current 54.6M USD +88.6%
Inventory, Net 2.67M USD -52.9%
Other Assets, Current 236K USD -88.1%
Assets, Current 157M USD +25.1%
Property, Plant and Equipment, Net 601K USD -33.7%
Operating Lease, Right-of-Use Asset 5.42M USD -36.6%
Assets 221M USD +8.41%
Accounts Payable, Current 7.51M USD +48.4%
Employee-related Liabilities, Current 4.36M USD +3.03%
Accrued Liabilities, Current 50.7M USD +50%
Liabilities, Current 110M USD +63.9%
Operating Lease, Liability, Noncurrent 2.95M USD -64.5%
Other Liabilities, Noncurrent 121K USD
Liabilities 150M USD -9.24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 26K USD
Retained Earnings (Accumulated Deficit) -1.33B USD +1.71%
Stockholders' Equity Attributable to Parent 71.1M USD +83.5%
Liabilities and Equity 221M USD +8.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.2M USD +326%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -19.1M USD -9.34%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49.1M shares +3.21%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.83M USD +47.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.91M USD 0%
Deferred Tax Assets, Valuation Allowance 369M USD -1.66%
Deferred Tax Assets, Gross 372M USD -1.58%
Operating Lease, Liability 8.3M USD -35.8%
Depreciation 400K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 23.3M USD +251%
Lessee, Operating Lease, Liability, to be Paid 8.95M USD -39.2%
Property, Plant and Equipment, Gross 8.58M USD -1.06%
Operating Lease, Liability, Current 5.35M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD -74.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.98M USD +3.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 659K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.51M USD -74.8%
Deferred Tax Assets, Operating Loss Carryforwards 241M USD -4.96%
Unrecognized Tax Benefits 2.81M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.51M USD 0%
Operating Lease, Payments 1.58M USD +5.34%
Amortization of Intangible Assets 9.7M USD +5.44%
Share-based Payment Arrangement, Expense 8.93M USD -14.5%
Interest Expense 13.4M USD +9.29%